# Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

> **NCT04755777** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 138 (actual)

## Conditions studied

- Sepsis
- Critical Illness

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04755777
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-22
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04755777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04755777, "Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04755777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*